Global In-situ Hybridization (ISH) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR112403497

Publication Date:

November 28, 2024

Pages:

102

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

IT & eHealth [2]

Pharma & Healthcare [3]

Description:

According to our latest research, the global In-situ Hybridization (ISH) market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
The In-situ Hybridization (ISH) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
In situ hybridization is used to reveal the location of specific nucleic acid sequences on chromosomes or in tissues, a crucial step for understanding the organization, regulation, and function of genes. The key techniques currently in use include: in situ hybridization to mRNA with oligonucleotide and RNA probes (both radio-labelled and hapten-labelled); analysis with light and electron microscopes; whole mount in situ hybridization; double detection of RNAs and RNA plus protein; and fluorescent in situ hybridization to detect chromosomal sequences. DNA ISH can be used to determine the structure of chromosomes. Fluorescent DNA ISH (FISH) can, for example, be used in medical diagnostics to assess chromosomal integrity. RNA ISH (RNA in situ hybridization) is used to measure and localize RNAs (mRNAs, lncRNAs, and miRNAs) within tissue sections, cells, whole mounts, and circulating tumor cells (CTCs).
Market segmentation
In-situ Hybridization (ISH) market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Market segment by Application, can be divided into
Molecular Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutions
Market segment by players, this report covers
ABBott Laboratories
F.Hoffmann-La Roche
Thermofisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher Corporation
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio SB
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe In-situ Hybridization (ISH) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In-situ Hybridization (ISH), with recent developments and future plans
Chapter 3, the In-situ Hybridization (ISH) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and In-situ Hybridization (ISH) market forecast, by regions, with revenue, from 2024 to 2030.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.
Chapter 7 and 8, to describe In-situ Hybridization (ISH) research findings and conclusion, appendix and data source.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of In-situ Hybridization (ISH)
1.2 Classification of In-situ Hybridization (ISH) by Type
1.2.1 Overview: Global In-situ Hybridization (ISH) Market Size by Type: 2024 Versus 2030
1.2.2 Global In-situ Hybridization (ISH) Revenue Market Share by Type in 2030
1.2.3 Fluorescence In Situ Hybridization (FISH)
1.2.4 Chromogenic In Situ Hybridization
1.3 Global In-situ Hybridization (ISH) Market by Application
1.3.1 Overview: Global In-situ Hybridization (ISH) Market Size by Application: 2024 Versus 2030
1.3.2 Molecular Diagnostic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Contract Research Organizations (CROs)
1.3.5 Academic & Research Institutions
1.4 Global In-situ Hybridization (ISH) Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 In-situ Hybridization (ISH) Market Drivers
1.5.2 In-situ Hybridization (ISH) Market Restraints
1.5.3 In-situ Hybridization (ISH) Trends Analysis
2 Company Profiles
2.1 ABBott Laboratories
2.1.1 ABBott Laboratories Details
2.1.2 ABBott Laboratories Major Business
2.1.3 ABBott Laboratories In-situ Hybridization (ISH) Product and Solutions
2.1.4 ABBott Laboratories Recent Developments and Future Plans
2.2 F.Hoffmann-La Roche
2.2.1 F.Hoffmann-La Roche Details
2.2.2 F.Hoffmann-La Roche Major Business
2.2.3 F.Hoffmann-La Roche In-situ Hybridization (ISH) Product and Solutions
2.2.4 F.Hoffmann-La Roche Recent Developments and Future Plans
2.3 Thermofisher Scientific
2.3.1 Thermofisher Scientific Details
2.3.2 Thermofisher Scientific Major Business
2.3.3 Thermofisher Scientific In-situ Hybridization (ISH) Product and Solutions
2.3.4 Thermofisher Scientific Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck In-situ Hybridization (ISH) Product and Solutions
2.4.4 Merck Recent Developments and Future Plans
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies In-situ Hybridization (ISH) Product and Solutions
2.5.4 Agilent Technologies Recent Developments and Future Plans
2.6 Perkin Elmer
2.6.1 Perkin Elmer Details
2.6.2 Perkin Elmer Major Business
2.6.3 Perkin Elmer In-situ Hybridization (ISH) Product and Solutions
2.6.4 Perkin Elmer Recent Developments and Future Plans
2.7 Danaher Corporation
2.7.1 Danaher Corporation Details
2.7.2 Danaher Corporation Major Business
2.7.3 Danaher Corporation In-situ Hybridization (ISH) Product and Solutions
2.7.4 Danaher Corporation Recent Developments and Future Plans
2.8 Exiqon
2.8.1 Exiqon Details
2.8.2 Exiqon Major Business
2.8.3 Exiqon In-situ Hybridization (ISH) Product and Solutions
2.8.4 Exiqon Recent Developments and Future Plans
2.9 Biogenex Laboratories
2.9.1 Biogenex Laboratories Details
2.9.2 Biogenex Laboratories Major Business
2.9.3 Biogenex Laboratories In-situ Hybridization (ISH) Product and Solutions
2.9.4 Biogenex Laboratories Recent Developments and Future Plans
2.10 Advanced Cell Diagnostics
2.10.1 Advanced Cell Diagnostics Details
2.10.2 Advanced Cell Diagnostics Major Business
2.10.3 Advanced Cell Diagnostics In-situ Hybridization (ISH) Product and Solutions
2.10.4 Advanced Cell Diagnostics Recent Developments and Future Plans
2.11 Bio SB
2.11.1 Bio SB Details
2.11.2 Bio SB Major Business
2.11.3 Bio SB In-situ Hybridization (ISH) Product and Solutions
2.11.4 Bio SB Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-situ Hybridization (ISH) Revenue and Share by Players (2024 & 2030)
3.2 In-situ Hybridization (ISH) Players Head Office, Products and Services Provided
3.3 In-situ Hybridization (ISH) Mergers & Acquisitions
3.4 In-situ Hybridization (ISH) New Entrants and Expansion Plans
4 Global In-situ Hybridization (ISH) Forecast by Region
4.1 Global In-situ Hybridization (ISH) Market Size by Region: 2024 VS 2030
4.2 Global In-situ Hybridization (ISH) Market Size by Region, (2024-2030)
4.3 North America
4.3.1 Key Companies of In-situ Hybridization (ISH) in North America
4.3.2 Current Situation and Forecast of In-situ Hybridization (ISH) in North America
4.3.3 North America In-situ Hybridization (ISH) Market Size and Prospect (2024-2030)
4.4 Europe
4.4.1 Key Companies of In-situ Hybridization (ISH) in Europe
4.4.2 Current Situation and Forecast of In-situ Hybridization (ISH) in Europe
4.4.3 Europe In-situ Hybridization (ISH) Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
4.5.1 Key Companies of In-situ Hybridization (ISH) in Asia-Pacific
4.5.2 Current Situation and Forecast of In-situ Hybridization (ISH) in Asia-Pacific
4.5.3 Asia-Pacific In-situ Hybridization (ISH) Market Size and Prospect (2024-2030)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of In-situ Hybridization (ISH) in South America
4.6.2 Current Situation and Forecast of In-situ Hybridization (ISH) in South America
4.6.3 South America In-situ Hybridization (ISH) Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
4.7.1 Key Companies of In-situ Hybridization (ISH) in Middle East & Africa
4.7.2 Current Situation and Forecast of In-situ Hybridization (ISH) in Middle East & Africa
4.7.3 Middle East & Africa In-situ Hybridization (ISH) Market Size and Prospect (2024-2030)
5 Market Size Segment by Type
5.1 Global In-situ Hybridization (ISH) Market Forecast by Type (2024-2030)
5.2 Global In-situ Hybridization (ISH) Market Share Forecast by Type (2024-2030)
6 Market Size Segment by Application
6.1 Global In-situ Hybridization (ISH) Market Forecast by Application (2024-2030)
6.2 Global In-situ Hybridization (ISH) Market Share Forecast by Application (2024-2030)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

Companies Mentioned:

ABBott Laboratories
F.Hoffmann-La Roche
Thermofisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher Corporation
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio SB

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂